首页> 外文期刊>Journal of Surgical Oncology >Long-term outcome and cost-effectiveness of complete versus assisted video-assisted thoracic surgery for non-small cell lung cancer.
【24h】

Long-term outcome and cost-effectiveness of complete versus assisted video-assisted thoracic surgery for non-small cell lung cancer.

机译:对于非小细胞肺癌,完整与辅助视频辅助胸外科手术的长期结果和成本效益。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To compare the outcomes and costs of two methods of video-assisted thoracoscopic surgery (VATS) major pulmonary resection in patients with clinically resectable non-small cell lung cancer (NSCLC). METHODS: Between January 2000 and December 2007, 1,058 patients with proven stages I-IIIA NSCLC underwent complete VATS (c-VATS) or assisted VATS (a-VATS) major pulmonary resection together with a systematic nodal dissection. RESULTS: The study cohort consisted of 736 men and 322 women. Mean operative time was shorter for the a-VATS cohort compared with the c-VATS group (P = 0.038). Overall survival (OS) at 5 years based on Kaplan-Meier analysis was 55.3% (95%CI, 50.6-60.0%) for those who underwent c-VATS and 47.7% (95%CI, 41.2-54.2%) for those who underwent a-VATS (P = 0.404). Gender, final pathology, TNM stage, and pT status were significant predictive factors for OS according to multivariate analysis. The total cost of a-VATS lobectomy was lower than that of c-VATS lobectomy. CONCLUSIONS: c-VATS and a-VATS yield similar results in patients with clinically resectable NSCLC. a-VATS, however, may be less expensive and easier to adopt, making it a particularly attractive option for thoracic surgeons in developing countries.
机译:背景:为了比较两种电视辅助胸腔镜手术(VATS)在临床上可切除的非小细胞肺癌(NSCLC)患者中的效果和成本。方法:从2000年1月至2007年12月,对1058例I-IIIA期NSCLC确诊的患者进行了完整的VATS(c-VATS)或辅助VATS(a-VATS)大肺切除及系统性淋巴结清扫术。结果:该研究队列由736名男性和322名女性组成。与c-VATS组相比,a-VATS组的平均手术时间短(P = 0.038)。根据Kaplan-Meier分析,接受c-VATS的患者5年总生存(OS)为55.3%(95%CI,50.6-60.0%),接受c-VATS的患者为47.7%(95%CI,41.2-54.2%)。进行了a-VATS(P = 0.404)。根据多变量分析,性别,最终病理,TNM分期和pT状态是OS的重要预测因素。 a-VATS肺叶切除术的总费用低于c-VATS肺叶切除术的费用。结论:c-VATS和a-VATS在临床可切除的NSCLC患者中产生相似的结果。然而,a-VATS可能更便宜且更易于采用,这使其成为发展中国家胸外科医师特别有吸引力的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号